Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Equity Ratio (2020 - 2025)

HCW Biologics (HCWB) has disclosed Equity Ratio for 6 consecutive years, with 0.08 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio rose 77.94% year-over-year to 0.08, compared with a TTM value of 0.08 through Sep 2025, up 77.94%, and an annual FY2024 reading of 0.22, down 147.43% over the prior year.
  • Equity Ratio was 0.08 for Q3 2025 at HCW Biologics, down from 0.0 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.97 in Q2 2022 and bottomed at 1.78 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.3, with a median of 0.57 recorded in 2023.
  • The sharpest move saw Equity Ratio soared 188.11% in 2021, then crashed 213.39% in 2025.
  • Year by year, Equity Ratio stood at 0.96 in 2021, then fell by 16.41% to 0.8 in 2022, then plummeted by 40.96% to 0.47 in 2023, then crashed by 147.43% to 0.22 in 2024, then soared by 63.01% to 0.08 in 2025.
  • Business Quant data shows Equity Ratio for HCWB at 0.08 in Q3 2025, 0.0 in Q2 2025, and 0.33 in Q1 2025.